The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas.

Find Out What It Is Right Here.

RPRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.86%

Insider Buying (Last 12 Months): $10,221,725.16

Insider Selling (Last 12 Months): $167,823,666.62

Royalty Pharma Insider Trading History Chart

Royalty Pharma Share Price & Price History

^$33.42

▲ +0.25 (0.75%)

As of 06/2/2023 01:00 AM ET

Days: 30 | 90 | 365

The Ultimate Passive Income Play

From The Oxford Club | Ad

>>>

Royalty Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/24/2023	Pablo G Legorreta	CEO	Buy	150,000	$32.25	$4,837,500.00	380,000
5/22/2023	Rory B. Riggs	Director	Sell	1,750,000	$32.82	$57,435,000.00	6,762
5/16/2023	Pablo G Legorreta	CEO	Buy	160,388	$33.57	$5,384,225.16	160,388
3/29/2023	Rory B. Riggs	Director	Sell	9,926	$36.95	$366,765.70	1,586,786
3/28/2023	George W. Lloyd	EVP	Sell	100,000	$37.06	$3,706,000.00	225,000
2/22/2023	Marshall Urist	EVP	Sell	23,333	$37.30	$870,320.90	46,667
12/12/2022	Rory B. Riggs	Director	Sell	40,010	$41.98	$1,679,619.80	96,712
12/9/2022	Rory B. Riggs	Director	Sell	19,990	$42.07	$840,979.30	136,722
12/5/2022	Mario Germano Giuliani	Director	Sell	84,302	$43.15	$3,637,631.30	7,795,072
12/1/2022	Mario Germano Giuliani	Director	Sell	165,000	$44.10	$7,276,500.00	22,225,000
11/21/2022	George W. Lloyd	EVP	Sell	23,631	$43.11	$1,018,732.41	144,469
11/17/2022	Rory B. Riggs	Director	Sell	120,000	$42.33	$5,079,600.00	156,712
11/10/2022	George W. Lloyd	EVP	Sell	50,000	$43.85	$2,192,500.00	165,000
11/8/2022	Terrance P Coyne	CFO	Sell	24,500	$43.47	$1,065,015.00	940,000
11/2/2022	Terrance P Coyne	CFO	Sell	5,500	$43.06	$236,830.00	964,500
9/28/2022	James F. Reddoch	EVP	Sell	100,000	$41.23	$4,123,000.00	820,800
9/28/2022	Mario Germano Giuliani	Director	Sell	32,593	$41.05	$1,337,942.65	8,077,140
9/21/2022	Mario Germano Giuliani	Director	Sell	125,697	$41.25	$5,185,001.25	8,321,113
9/20/2022	1978 Sicaf Sif S.A. - Gg St Gg	Major Shareholder	Sell	267,815	$41.02	$10,985,771.30	21,426,170
9/19/2022	Mario Germano Giuliani	Director	Sell	232,185	$41.50	$9,635,677.50	22,657,815
9/16/2022	Mario Germano Giuliani	Director	Sell	154,986	$41.72	$6,466,015.92	22,890,000
9/14/2022	1978 Sicaf Sif S.A. Gg	Major Shareholder	Sell	190,860	$42.48	$8,107,732.80	22,235,310
9/14/2022	Rory B. Riggs	Director	Sell	47,975	$42.41	$2,034,619.75	328,737
9/7/2022	1978 Sicaf Sif S.A. - Gg St Gg	Major Shareholder	Sell	250,000	$42.53	$10,632,500.00	22,674,176
9/7/2022	Mario Germano Giuliani	Director	Sell	261,881	$42.66	$11,171,843.46	8,814,759
8/25/2022	1978 Sicaf Sif S.A. - Gg St Gg	Major Shareholder	Sell	1,994	$44.00	$87,736.00	22,924,176
8/25/2022	Mario Germano Giuliani	Director	Sell	500	$44.00	$22,000.00	9,076,640
8/9/2022	George W. Lloyd	EVP	Sell	11,859	$43.92	$520,847.28	210,109
8/9/2022	Rory B. Riggs	Director	Sell	45,000	$43.73	$1,967,850.00	376,712
8/1/2022	Terrance P Coyne	CFO	Sell	30,000	$43.19	$1,295,700.00	970,000
7/27/2022	George W. Lloyd	EVP	Sell	25,100	$43.76	$1,098,376.00	226,014
7/25/2022	George W. Lloyd	EVP	Sell	30,671	$42.93	$1,316,706.03	228,886
6/29/2022	Rory B. Riggs	Director	Sell	30,000	$42.17	$1,265,100.00	421,712
6/24/2022	Marshall Urist	EVP	Sell	23,333	$43.19	$1,007,752.27	23,334
6/8/2022	James F. Reddoch	EVP	Sell	100,000	$41.56	$4,156,000.00	920,800
5/27/2022	James F. Reddoch	EVP	Sell	75,000	$41.08	$3,081,000.00	1,020,800
5/23/2022	George W. Lloyd	EVP	Sell	100,000	$40.27	$4,027,000.00	530,000
5/19/2022	James F. Reddoch	EVP	Sell	75,000	$40.44	$3,033,000.00	1,095,800
5/19/2022	Rory B. Riggs	Director	Sell	26,304	$40.09	$1,054,527.36	575,408
5/16/2022	Marshall Urist	EVP	Sell	23,333	$39.85	$929,820.05	46,667
3/29/2022	Rory B. Riggs	Director	Sell	60,000	$38.59	$2,315,400.00
3/21/2022	Rory B. Riggs	Director	Sell	39,867	$39.05	$1,556,806.35
3/18/2022	Rory B. Riggs	Director	Sell	129,222	$39.55	$5,110,730.10
2/24/2022	Henry A. Fernandez	Director	Buy	32,500	$37.49	$1,218,425.00
12/28/2021	Rory B. Riggs	Director	Sell	109,448	$40.21	$4,400,904.08
11/16/2021	George W. Lloyd	EVP	Sell	165,852	$42.39	$7,030,466.28
11/16/2021	Rory B. Riggs	Director	Sell	12,565	$42.01	$527,855.65
9/28/2021	Rory B. Riggs	Director	Sell	40,000	$36.75	$1,470,000.00
7/26/2021	George W. Lloyd	EVP	Sell	13,362	$39.78	$531,540.36
7/14/2021	James F. Reddoch	EVP	Sell	2	$42.00	$84.00
7/12/2021	George W. Lloyd	EVP	Sell	100	$42.04	$4,204.00	3,000
7/8/2021	James F. Reddoch	EVP	Sell	40,655	$42.05	$1,709,542.75	3,000
7/6/2021	James F. Reddoch	EVP	Sell	30,270	$42.40	$1,283,448.00	3,000
6/28/2021	Rory B. Riggs	Director	Sell	167,448	$42.11	$7,051,235.28	679,760
6/25/2021	Rory B. Riggs	Director	Sell	666,464	$42.72	$28,471,342.08	679,760
6/10/2021	George W. Lloyd	EVP	Sell	70,000	$46.49	$3,254,300.00	3,000
6/7/2021	Marshall Urist	EVP	Sell	16,568	$47.02	$779,027.36	16,568
6/4/2021	Marshall Urist	EVP	Sell	16,566	$45.13	$747,623.58	16,568
6/2/2021	Marshall Urist	EVP	Sell	14,566	$41.52	$604,780.32
4/14/2021	George W. Lloyd	EVP	Sell	69,822	$42.13	$2,941,600.86	3,000
4/12/2021	George W. Lloyd	EVP	Sell	449	$42.32	$19,001.68	3,000
3/22/2021	James F. Reddoch	EVP	Sell	43,927	$46.32	$2,034,698.64	3,000
3/2/2021	George W. Lloyd	EVP	Sell	125,000	$46.94	$5,867,500.00	3,000
3/2/2021	Terrance P Coyne	CFO	Sell	100,000	$46.94	$4,694,000.00	1,500
2/25/2021	Henry A. Fernandez	Director	Buy	25,700	$46.83	$1,203,531.00	8,713
12/18/2020	Adage Capital Partners Gp, L.L	Major Shareholder	Sell	7,301,050	$43.92	$320,662,116.00
10/20/2020	Rory B. Riggs	Director	Sell	463,200	$42.00	$19,454,400.00	463,200
6/18/2020	Adage Capital Partners Gp, L.L	Major Shareholder	Buy	3,000,000	$28.00	$84,000,000.00
6/18/2020	George W. Lloyd	EVP	Buy	3,000	$28.00	$84,000.00	3,000
6/18/2020	Pablo G Legorreta	CEO	Buy	20,000	$28.00	$560,000.00
6/18/2020	Terrance P Coyne	CFO	Buy	1,500	$28.00	$42,000.00	1,500
6/18/2020	William E. Ford	Director	Buy	1,500,000	$28.00	$42,000,000.00

The Ultimate Passive Income Play

From The Oxford Club | Ad

>>>

SEC Filings (Institutional Ownership Changes) for Royalty Pharma (NASDAQ:RPRX)

55.36% of Royalty Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Royalty Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/1/2023	Ontario Teachers Pension Plan Board	11,958	$0.43M	0.0%	-51.8%	0.002%
5/26/2023	ProShare Advisors LLC	30,724	$1.11M	0.0%	-27.0%	0.005%
5/23/2023	Toroso Investments LLC	55,984	$2.02M	0.1%	+8.7%	0.009%
5/22/2023	Ameriprise Financial Inc.	1,485,436	$53.52M	0.0%	+7.1%	0.245%
5/19/2023	Geo Capital Gestora de Recursos Ltd	142,748	$5.14M	3.8%	+15.0%	0.024%
5/18/2023	JPMorgan Chase & Co.	8,671,563	$312.44M	0.0%	+2.9%	1.428%
5/17/2023	B. Riley Wealth Advisors Inc.	13,650	$0.49M	0.0%	-28.7%	0.002%
5/17/2023	Rockefeller Capital Management L.P.	24,890	$0.90M	0.0%	-73.5%	0.004%
5/16/2023	State Street Corp	8,340,805	$300.52M	0.0%	+2.7%	1.374%
5/16/2023	Squarepoint Ops LLC	514,709	$18.55M	0.1%	+79.2%	0.085%
5/16/2023	First Trust Advisors LP	10,462	$0.38M	0.0%	-91.9%	0.002%
5/16/2023	Geode Capital Management LLC	5,992,126	$215.64M	0.0%	+2.8%	0.987%
5/16/2023	Graham Capital Management L.P.	15,792	$0.57M	0.0%	-77.8%	0.003%
5/16/2023	Arrowstreet Capital Limited Partnership	1,956,125	$70.48M	0.1%	-21.7%	0.322%
5/16/2023	Alyeska Investment Group L.P.	638,394	$23M	0.2%	+24.4%	0.105%
5/15/2023	Schonfeld Strategic Advisors LLC	51,015	$1.84M	0.0%	-76.1%	0.008%
5/15/2023	Cubist Systematic Strategies LLC	22,214	$0.80M	0.0%	-91.3%	0.004%
5/15/2023	Nomura Holdings Inc.	7,250	$0.26M	0.0%	N/A	0.001%
5/15/2023	Public Employees Retirement System of Ohio	189,320	$6.82M	0.0%	-2.5%	0.031%
5/15/2023	Portolan Capital Management LLC	212,453	$7.66M	0.7%	N/A	0.035%
5/15/2023	Lagoda Investment Management L.P.	101,500	$3.66M	2.6%	-14.8%	0.017%
5/15/2023	Suvretta Capital Management LLC	3,047,049	$109.79M	4.6%	+54.3%	0.502%
5/15/2023	Two Sigma Securities LLC	6,933	$0.25M	0.0%	N/A	0.001%
5/15/2023	Two Sigma Advisers LP	316,600	$11.41M	0.0%	-46.1%	0.052%
5/15/2023	Two Sigma Investments LP	174,284	$6.28M	0.0%	-60.4%	0.029%
5/15/2023	Deutsche Bank AG	533,064	$19.21M	0.0%	-12.3%	0.088%
5/15/2023	Ensign Peak Advisors Inc	870,814	$31.38M	0.1%	-23.9%	0.143%
5/15/2023	Price T Rowe Associates Inc. MD	2,475,947	$89.21M	0.0%	-1.1%	0.408%
5/15/2023	Nissay Asset Management Corp Japan ADV	36,960	$1.33M	0.0%	-3.3%	0.006%
5/15/2023	Fort L.P.	6,641	$0.24M	0.6%	-11.8%	0.001%
5/15/2023	Healthcare of Ontario Pension Plan Trust Fund	35,922	$1.29M	0.0%	+210.2%	0.006%
5/15/2023	Ossiam	3,661	$0.13M	0.0%	+22.3%	0.001%
5/15/2023	Overbrook Management Corp	578,783	$20.85M	5.5%	-5.0%	0.095%
5/15/2023	XTX Topco Ltd	9,275	$0.33M	0.1%	-24.3%	0.002%
5/12/2023	Renaissance Technologies LLC	1,300,900	$46.87M	0.1%	+49.7%	0.214%
5/12/2023	Stifel Financial Corp	6,228	$0.22M	0.0%	N/A	0.001%
5/12/2023	Caisse DE Depot ET Placement DU Quebec	71,400	$2.57M	0.0%	N/A	0.012%
5/12/2023	BlackRock Inc.	19,848,842	$715.15M	0.0%	+2.2%	3.269%
5/12/2023	Argent Trust Co	7,824	$0.28M	0.0%	-8.7%	0.001%
5/12/2023	Bank of America Corp DE	1,882,410	$67.82M	0.0%	+42.2%	0.310%
5/12/2023	Ontario Teachers Pension Plan Board	11,958	$0.43M	0.0%	-51.8%	0.002%
5/12/2023	Franklin Resources Inc.	40,720	$1.47M	0.0%	-2.6%	0.007%
5/12/2023	L2 Asset Management LLC	67,057	$2.42M	1.3%	+19.5%	0.011%
5/12/2023	Philadelphia Trust Co.	213,430	$7.69M	0.8%	-3.0%	0.035%
5/12/2023	UBS Group AG	501,955	$18.09M	0.0%	-31.7%	0.083%
5/12/2023	Elo Mutual Pension Insurance Co	28,307	$1.02M	0.0%	+4.6%	0.005%
5/12/2023	Sei Investments Co.	27,187	$0.98M	0.0%	+83.4%	0.004%
5/12/2023	Dimensional Fund Advisors LP	389,959	$14.05M	0.0%	+20.0%	0.064%
5/12/2023	Aviva PLC	19,030	$0.69M	0.0%	-61.9%	0.003%
5/12/2023	Wellington Management Group LLP	52,250	$1.88M	0.0%	-98.5%	0.009%
5/12/2023	Panagora Asset Management Inc.	49,348	$1.78M	0.0%	+56.3%	0.008%
5/12/2023	Korea Investment CORP	68,412	$2.47M	0.0%	+6.5%	0.011%
5/12/2023	First Republic Investment Management Inc.	13,714	$0.49M	0.0%	-10.8%	0.002%
5/12/2023	Executive Wealth Management LLC	20,590	$0.74M	0.1%	N/A	0.003%
5/12/2023	Profund Advisors LLC	17,470	$0.63M	0.0%	-17.4%	0.003%
5/12/2023	Charles Schwab Investment Management Inc.	1,407,537	$50.71M	0.0%	+3.4%	0.232%
5/12/2023	Rhenman & Partners Asset Management AB	165,000	$5.99M	0.7%	-23.3%	0.027%
5/12/2023	HighTower Advisors LLC	164,071	$5.90M	0.0%	+3.2%	0.027%
5/11/2023	Nomura Asset Management Co. Ltd.	85,852	$3.09M	0.0%	+7.5%	0.014%
5/11/2023	BOKF NA	5,002	$0.18M	0.0%	N/A	0.001%
5/11/2023	Balentine LLC	7,934	$0.29M	0.0%	N/A	0.001%
5/11/2023	Acadian Asset Management LLC	3,142	$0.11M	0.0%	N/A	0.001%
5/11/2023	Synovus Financial Corp	99,169	$3.57M	0.0%	+6.6%	0.016%
5/11/2023	FIL Ltd	19,306	$0.70M	0.0%	+144.4%	0.003%
5/11/2023	M&T Bank Corp	14,230	$0.51M	0.0%	-24.3%	0.002%
5/11/2023	Cornercap Investment Counsel Inc.	24,179	$0.87M	0.2%	N/A	0.004%
5/11/2023	FMR LLC	39,984,116	$1.44B	0.1%	-9.4%	6.585%
5/11/2023	Cerity Partners LLC	24,845	$0.89M	0.0%	+2.9%	0.004%
5/11/2023	ExodusPoint Capital Management LP	197,915	$7.13M	0.1%	+24.5%	0.033%
5/11/2023	American Century Companies Inc.	40,134	$1.45M	0.0%	+17.3%	0.007%
5/11/2023	Envestnet Asset Management Inc.	15,825	$0.57M	0.0%	+22.4%	0.003%
5/11/2023	Kovitz Investment Group Partners LLC	73,832	$2.66M	0.0%	-4.9%	0.012%
5/11/2023	Rhumbline Advisers	418,306	$15.07M	0.0%	+1.7%	0.069%
5/11/2023	Commonwealth Equity Services LLC	6,631	$0.24M	0.0%	N/A	0.001%
5/11/2023	Citigroup Inc.	171,944	$6.20M	0.0%	+67.3%	0.028%
5/11/2023	Guggenheim Capital LLC	110,854	$3.99M	0.0%	-12.4%	0.018%
5/10/2023	Intech Investment Management LLC	14,986	$0.54M	0.0%	-6.9%	0.002%
5/10/2023	Credit Suisse AG	500,531	$18.03M	0.0%	+21.9%	0.082%
5/10/2023	Pictet Asset Management SA	578,278	$20.84M	0.0%	+169.3%	0.095%
5/10/2023	Swiss National Bank	1,400,400	$50.46M	0.0%	-1.5%	0.231%
5/10/2023	Tredje AP fonden	119,041	$4.29M	0.1%	+68.4%	0.020%
5/10/2023	TimesSquare Capital Management LLC	1,267,830	$45.68M	0.7%	-18.0%	0.209%
5/10/2023	Mitsubishi UFJ Trust & Banking Corp	1,588,865	$57.25M	0.1%	+6.3%	0.262%
5/9/2023	Principal Financial Group Inc.	37,150	$1.34M	0.0%	+4.3%	0.006%
5/9/2023	Formidable Asset Management LLC	32,858	$1.18M	0.2%	+32.9%	0.005%
5/9/2023	Tower Research Capital LLC TRC	1,973	$71K	0.0%	-85.7%	0.000%
5/9/2023	S&CO Inc.	152,930	$5.51M	0.5%	-4.4%	0.025%
5/9/2023	Bank of New York Mellon Corp	1,714,000	$61.76M	0.0%	-3.3%	0.282%
5/9/2023	California State Teachers Retirement System	592,431	$21.35M	0.0%	-0.5%	0.098%
5/9/2023	US Bancorp DE	5,539	$0.20M	0.0%	+27.2%	0.001%
5/9/2023	Altshuler Shaham Ltd	1,208	$44K	0.0%	N/A	0.000%
5/9/2023	Russell Investments Group Ltd.	426,608	$15.40M	0.0%	+11.8%	0.070%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	87,133	$3.16M	0.0%	+27.2%	0.014%
5/8/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	119,312	$4.30M	0.0%	+11.3%	0.020%
5/8/2023	Sageworth Trust Co	856	$31K	0.0%	N/A	0.000%
5/8/2023	Donoghue Forlines LLC	18,435	$0.66M	0.2%	+234.0%	0.003%
5/5/2023	Truist Financial Corp	38,731	$1.40M	0.0%	+1.3%	0.006%
5/5/2023	Versor Investments LP	22,800	$0.82M	0.1%	-30.5%	0.004%
5/4/2023	Commerce Bank	7,346	$0.27M	0.0%	N/A	0.001%
5/4/2023	Summit Global Investments	141,381	$5.09M	0.4%	+2.3%	0.023%

Data available starting January 2016

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Today's Range

Now: $33.42

$33.27

$33.80

50 Day Range

MA: $34.94

$32.22

$37.39

52 Week Range

Now: $33.42

$32.02

$44.66

Volume

2,825,358 shs

Average Volume

2,325,918 shs

Market Capitalization

$20.29 billion

P/E Ratio

60.76

Dividend Yield

2.41%

Beta

0.42

Who are the company insiders with the largest holdings of Royalty Pharma?: Royalty Pharma's top insider shareholders include:
1978 Sicaf Sif SA - Gg St Gg (Major Shareholder)
Mario Germano Giuliani (Director)
1978 Sicaf Sif SA Gg (Major Shareholder)
Rory B Riggs (Director)
James F Reddoch (EVP)
Terrance P Coyne (CFO)
George W Lloyd (EVP)
Pablo G Legorreta (CEO)
Marshall Urist (EVP)
James F Reddoch (EVP)
Henry A Fernandez (Director)
Scientific Corp Boston (Major Shareholder)
Learn More about top insider investors at Royalty Pharma.
Who are the major institutional investors of Royalty Pharma?: Royalty Pharma's top institutional investors include:
FMR LLC — 6.58%
BlackRock Inc. — 3.27%
Baillie Gifford & Co. — 3.12%
JPMorgan Chase & Co. — 1.43%
State Street Corp — 1.37%
Geode Capital Management LLC — 0.99%
Learn More about top institutional investors of Royalty Pharma stock.
Which major investors are selling Royalty Pharma stock?: During the last quarter, RPRX stock was sold by these institutional investors:
FMR LLC
Wellington Management Group LLP
Allspring Global Investments Holdings LLC
Arrowstreet Capital Limited Partnership
TimesSquare Capital Management LLC
Ensign Peak Advisors Inc
Two Sigma Advisers LP
Two Sigma Investments LP
During the last year, company insiders that have sold Royalty Pharma company stock include:
1978 Sicaf Sif SA - Gg St Gg (Major Shareholder)
Mario Germano Giuliani (Director)
1978 Sicaf Sif SA Gg (Major Shareholder)
Rory B Riggs (Director)
James F Reddoch (EVP)
Terrance P Coyne (CFO)
George W Lloyd (EVP)
Pablo G Legorreta (CEO)
Learn More investors selling Royalty Pharma stock.
Which major investors are buying Royalty Pharma stock?: Within the last quarter, RPRX stock was bought by institutional investors including:
Baillie Gifford & Co.
Suvretta Capital Management LLC
Bank of America Corp DE
abrdn plc
BlackRock Inc.
Renaissance Technologies LLC
Pictet Asset Management SA
Los Angeles Capital Management LLC
In the last year, these company insiders have bought Royalty Pharma stock:
1978 Sicaf Sif SA - Gg St Gg (Major Shareholder)
Mario Germano Giuliani (Director)
Learn More investors buying Royalty Pharma stock.

The Ultimate Passive Income Play

From The Oxford Club | Ad

>>>

RPRX Insider Trading

Royalty Pharma Insider Trading History Chart

Royalty Pharma Share Price & Price History

Royalty Pharma Insider Trading History

SEC Filings (Institutional Ownership Changes) for Royalty Pharma (NASDAQ:RPRX)

Institutional Buying and Selling by Quarter

Royalty Pharma Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Royalty Pharma?

Who are the major institutional investors of Royalty Pharma?

Which major investors are selling Royalty Pharma stock?

Which major investors are buying Royalty Pharma stock?